DNA Mismatch Repair Deficiency Accelerates Endometrial Tumorigenesis in Pten Heterozygous Mice

Tashiro, 1997, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies, Cancer Res, 57, 3935 Kong, 1997, PTEN is frequently mutated in primary endometrial carcinomas, Nat Genet, 17, 143, 10.1038/ng1097-143 Risinger, 1998, PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics, Clin Cancer Res, 4, 3005 Simpkins, 1998, PTEN mutations in endometrial cancers with 10qLOH: additional evidence for the involvement of multiple tumor suppressors, Gynecol Oncol, 71, 391, 10.1006/gyno.1998.5208 Mutter, 2000, Altered PTEN expression as a diagnostic marker for the earliest endometrial, J Natl Cancer Inst, 92, 924, 10.1093/jnci/92.11.924 MacDonald, 2000, Frequency and prognostic impact of microsatellite instability in a larger population-based study of endometrial carcinomas, Cancer Res, 60, 1750 Gurin, 1999, Cause and consequences of microsatellite instability in endometrial carcinoma, Cancer Res, 59, 462 Levine, 1998, PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma, Cancer Res, 58, 3254 Maxwell, 1998, Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias, Cancer Res, 58, 2500 Maxwell, 2001, Favorable survival associated with microsatellite instability in endometrioid endometrial cancers, Obstet Gynecol, 97, 417 Bussaglia, 2000, PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases, Hum Pathol, 31, 312, 10.1016/S0046-8177(00)80244-0 Podsypanina, 1999, Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, Proc Natl Acad Sci USA, 96, 1563, 10.1073/pnas.96.4.1563 Stambolic, 2000, High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in Pten+/− mice, Cancer Res, 60, 3605 Edelmann, 1996, Meiotic pachytene arrest in MLH1-deficient mice, Cell, 85, 1125, 10.1016/S0092-8674(00)81312-4 Tashiro, 1997, Microsatellite instability is uncommon in uterine serous carcinoma, Am J Pathol, 150, 75 Yao, 1999, Different mutator phenotypes in Mlh1-versus Pms2-deficient mice, Proc Natl Acad Sci USA, 96, 6850, 10.1073/pnas.96.12.6850 Blake, 2001, Stepwise deletions of polyA sequences in mismatch repair-deficient colorectal cancers, Am J Pathol, 158, 1867, 10.1016/S0002-9440(10)64143-0 Staebler, 2000, Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability, Hum Pathol, 31, 354, 10.1016/S0046-8177(00)80250-6 Esteller, 1998, MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas, Oncogene, 17, 2413, 10.1038/sj.onc.1202178 Esteller, 1999, hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis, Am J Pathol, 155, 1767, 10.1016/S0002-9440(10)65492-2 Salvesen, 2000, Methylation of hMLH1 in a population-based series of endometrial carcinomas, Clin Cancer Res, 6, 3607 Parc, 2000, Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology, Int J Cancer, 86, 60, 10.1002/(SICI)1097-0215(20000401)86:1<60::AID-IJC9>3.0.CO;2-3 Prolla, 1998, Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms2 and Pms2 DNA mismatch repair, Nat Genet, 18, 276, 10.1038/ng0398-276 Heyer, 1999, Mouse models for colorectal cancer, Oncogene, 18, 5325, 10.1038/sj.onc.1203036 Prolla, 1996, DNA mismatch repair deficient mice in cancer research, Semin Cancer Biol, 7, 241, 10.1006/scbi.1996.0032 Edelmann, 1999, Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice, Cancer Res, 59, 1301 Huang, 1996, APC mutations in colorectal tumors with mismatch repair deficiency, Proc Natl Acad Sci USA, 93, 9049, 10.1073/pnas.93.17.9049 Cohn, 2000, Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability, Gynecol Oncol, 79, 101, 10.1006/gyno.2000.5900 Stambolic, 1998, Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN, Cell, 95, 29, 10.1016/S0092-8674(00)81780-8 Sun, 1999, PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway, Proc Natl Acad Sci USA, 96, 6199, 10.1073/pnas.96.11.6199 Dahia, 1999, PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in hematological malignancies, Hum Mol Genet, 8, 185, 10.1093/hmg/8.2.185